David J. Brillon - Concepedia

Author

David J. Brillon

Also Known As

Brillon, David J., D Brillon, D. Brillon, D. J. Brillon, D.J. Brillon, DAVID J. BRILLON, David Brillon, David J Brillon, David J. Brillon, Dennis Wallace

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Cornell University NewYork–Presbyterian Hospital New York Hospital Queens Columbia University George Washington University

About

David J. Brillon is an author at Cornell University specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	554
2	Health Sciences	5	5	452
3	Public Health	3	3	82
4	Biochemistry	1	1	80
5	Cell Biology	1	1	87

David J. Brillon

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality Trevor J. Orchard, David M. Nathan, Bernard Zinman, JAMA	2015	433
Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial Matthew C. Riddle, Walter T. Ambrosius, David J. Brillon, Diabetes Care	2010	396
Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort Zhuo Chen, Miao Feng, Andrew D. Paterson, Proceedings of the National Academy of Sciences	2016	238
Effect of cortisol on energy expenditure and amino acid metabolism in humans David J. Brillon, Bisheng Zheng, Robert G. Campbell, American Journal of Physiology-Endocrinology and Metabolism NutritionEnergy ExpenditureCortisol InfusionGlucocorticoidMetabolic Syndrome	1995	212
First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes Diana L. Cousminer, Emma Ahlqvist, Rajashree Mishra, Diabetes Care	2018	130
Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Jonathan Q. Purnell, Barbara H. Braffett, Bernard Zinman, Diabetes Care	2017	112
Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes Jerrold M. Olefsky, W. Timothy Garvey, Robert R. Henry, The American Journal of Medicine Insulin ResistanceMetabolic SyndromeInsulin SignalingSignal TransductionPhysiology	1988	87
Oxidation of glutamic acid by the splanchnic bed in humans Alberto Battezzati, David J. Brillon, Dwight E. Matthews American Journal of Physiology-Endocrinology and Metabolism Glutamic AcidRedox BiologyOxidative StressBioanalysisTracer Infusion	1995	80
Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Denise E. Bonds, Ella Mae Kurashige, Richard M. Bergenstal, The American Journal of Cardiology Metabolic SyndromeDiabetes ManagementSevere Hypoglycemia MonitoringHealth PolicyCardiovascular Disease	2007	52
Epinephrine produces a prolonged elevation in metabolic rate in humans Klaus Ratheiser, David J. Brillon, Robert G. Campbell, American Journal of Clinical Nutrition Metabolic SyndromeMetabolic RateEnergy HomeostasisAdrenal GlandEndocrine Mechanism	1998	45

Page 1